In this study, we showed that IRF4 transcriptionally induces both PD-L1 and PD1 expression in EBV lymphoma cells and co-cultured T cells, respectively, resulting in the evasion of the PD-L1/PD1 anti-tumor T cell response. Here, IRF4 is linked to neoplasm.